Effect of intralenticular dexamethasone implant: A case report.

Adriano Carnevali Andrea Taloni Valentina GattiLuca LamonicaFlavia OliverioGiorgio RandazzoVincenzo Scorcia

Published in: European journal of ophthalmology (2023)

The therapeutic effect of DEX implant can be maintained for a longer period of time than intravitreal implant, determining complete reabsorption of macular oedema. Intralenticular implant can be maintained inside the lens until either IOP increases, cataract progresses, or other complications occur.

Keyphrases

soft tissue
low dose
diabetic retinopathy
high dose
cataract surgery
risk factors
vascular endothelial growth factor
age related macular degeneration
endothelial cells